Mark Adams, PhD

Mark Adams is a Partner at Two Bear Capital, where he focuses on life sciences, artificial intelligence, and cybersecurity companies. Mark was most recently COO and CTO at Adaptive Biotechnologies, a public biotechnology company in Seattle, WA. He has previously had C-Suite roles in several biotechnology companies, as well as leading a consulting practice at Booz Allen Hamilton. He has also led artificial intelligence and data science teams in finance at Bridgewater Associates and Leerink Partners. Mark holds a PhD in Molecular Biology from Baylor College of Medicine and he earned his BA in Biology and Computer Science from Oberlin College.